Conscious Sedation-related Indications

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-08-26
EMA Authorised: Byfavo (remimazolam besilate) — Paion Pharma GmbH
Authorised status for Byfavo (remimazolam besilate) by Paion Pharma GmbH for conscious sedation.